Metformin Hydrochloride Zentiva (Metformin Hydrochloride)

Metformin works primarily by activating AMP‑activated protein kinase (AMPK), which suppresses hepatic gluconeogenesis and enhances peripheral glucose uptake. This dual action reduces the amount of glucose released into the bloodstream and improves insulin sensitivity in muscle and fat tissues.

The dosage of Metformin Hydrochloride Zentiva is individualized by the prescribing healthcare professional based on the patient’s clinical condition, renal function, and response to therapy. The prescriber determines the appropriate strength, frequency, and titration schedule.

Metformin Hydrochloride is classified as pregnancy category unknown; its use during pregnancy should be considered only if the potential benefit justifies the potential risk to the fetus. Limited data suggest it may be excreted in breast milk, so breastfeeding mothers should discuss risks and benefits with their clinician.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any special handling), and necessary import documentation.

Metformin is a first‑line Biguanide that lowers glucose without causing hypoglycemia when used alone, unlike sulfonylureas which stimulate insulin release. Compared with newer agents such as DPP‑4 inhibitors or SGLT2 inhibitors, metformin is generally less expensive, has a well‑established safety profile, and offers modest weight loss benefits.

Metformin Hydrochloride Zentiva should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the container tightly closed and out of reach of children.

The medication is taken orally, usually with meals to reduce gastrointestinal discomfort. Tablets should be swallowed whole with a full glass of water; they are not intended to be crushed, chewed, or dissolved unless specifically instructed by a healthcare professional.

The most serious risk is lactic acidosis, a rare but potentially fatal condition characterized by rapid breathing, muscle pain, and abdominal discomfort. Other serious concerns include severe skin reactions such as Stevens‑Johnson syndrome and significant hepatic dysfunction. Prompt medical attention is required if any of these symptoms appear.

Metformin is contraindicated in patients with severe renal impairment (eGFR < 30 mL/min/1.73 m²), acute or chronic metabolic acidosis, known hypersensitivity to metformin, or those receiving iodinated contrast media for imaging studies. Caution is also advised for individuals with liver disease, heart failure, or a history of lactic acidosis.